Literature DB >> 31065964

Survival Benefit of the Surgical Management of Retroperitoneal Sarcoma in a Reference Center: A Nationwide Study of the French Sarcoma Group from the NetSarc Database.

S Bonvalot1, E Gaignard2, E Stoeckle3, P Meeus4, G Decanter5, S Carrere6, C Honore7, J B Delhorme8, M Fau9, D Tzanis2, S Causeret10, P Gimbergues11, J M Guillois12, B Meunier13, A Le Cesne14, F Ducimetiere15, M Toulmonde16, J Y Blay17.   

Abstract

BACKGROUND: Guidelines recommend that retroperitoneal sarcoma (RPS) be managed in a reference sarcoma center (RSC), but the benefit remains to be demonstrated. This study investigated the impact of initial surgery performed within the NetSarc network on overall survival (OS).
METHODS: NetSarc is a network of 26 RSCs with specialized multidisciplinary tumor boards (MDTs) that is funded by the French NCI. Since 2010, presentation to an MDT and second pathological review are mandatory for sarcoma patients, and data have been collected in a nationwide database. We extracted data for all patients who received surgery in or outside the network and who presented at a NetSarc center (NSC) for primary nonmetastatic RPS between 2010 and 2017.
RESULTS: A total of 2945 patients were included: 1078 (36.6%) underwent the first surgery in an NSC, and 1867 (63.4%) in an out-of-network center. The median number of operations at an NSC during the study period was 23 (range: 3-209), and the corresponding median was 1 (range: 1-2) at out-of-network centers. The diagnostic procedures followed significantly more clinical practice guidelines within NetSarc, where there were significantly more first R0 resections [452 (41.9%) vs. 230 (12.3%)]. The OS was significantly superior for patients treated within NetSarc, with a 2-year OS of 87% vs. 70% (p < 0.001). In the multivariate analysis, surgery within an NSC was an independent predictor of OS, with a twofold lower odds ratio of death.
CONCLUSIONS: In this national study, surgery for primary RPS within an NSC was associated with a better OS.

Entities:  

Mesh:

Year:  2019        PMID: 31065964     DOI: 10.1245/s10434-019-07421-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  15 in total

Review 1.  [Late complications following neo-/adjuvant radiotherapy and surgery for sarcomas of the extremities or pelvis/retroperitoneum : Preventative measures].

Authors:  C Jentsch; C Hofbauer; S Makocki; E Troost
Journal:  Orthopade       Date:  2020-02       Impact factor: 1.087

Review 2.  Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.

Authors:  William W Tseng; Carol J Swallow; Dirk C Strauss; Sylvie Bonvalot; Piotr Rutkowski; Samuel J Ford; Ricardo J Gonzalez; Rebecca A Gladdy; David E Gyorki; Mark Fairweather; Kyo Won Lee; Markus Albertsmeier; Winan J van Houdt; Magalie Fau; Carolyn Nessim; Giovanni Grignani; Kenneth Cardona; Vittorio Quagliuolo; Valerie Grignol; Jeffrey M Farma; Elisabetta Pennacchioli; Marco Fiore; Andrew Hayes; Dimitri Tzanis; Jacek Skoczylas; Max L Almond; John E Mullinax; Wendy Johnston; Hayden Snow; Rick L Haas; Dario Callegaro; Myles J Smith; Toufik Bouhadiba; Anant Desai; Rachel Voss; Roberta Sanfilippo; Robin L Jones; Elizabeth H Baldini; Andrew J Wagner; Charles N Catton; Silvia Stacchiotti; Khin Thway; Christina L Roland; Chandrajit P Raut; Alessandro Gronchi
Journal:  Ann Surg Oncol       Date:  2022-06-29       Impact factor: 4.339

Review 3.  Radiation Therapy for Soft Tissue Sarcoma: Indications, Timing, Benefits, and Consequences.

Authors:  Kilian E Salerno
Journal:  Surg Clin North Am       Date:  2022-06-24       Impact factor: 3.537

Review 4.  Retroperitoneal Sarcomas: a Current Review on Management.

Authors:  Shraddha Patkar; Abhay K Kattepur; Nehal Khanna; Jyoti Bajpai
Journal:  Indian J Surg Oncol       Date:  2022-02-21

Review 5.  Landmark Series: A Review of Landmark Studies in the Treatment of Primary Localized Retroperitoneal Sarcoma.

Authors:  Megan Delisle; David Gyorki; Sylvie Bonvalot; Carolyn Nessim
Journal:  Ann Surg Oncol       Date:  2022-09-10       Impact factor: 4.339

6.  No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?

Authors:  Yohan Fayet; Christine Chevreau; Gauthier Decanter; Cécile Dalban; Pierre Meeus; Sébastien Carrère; Leila Haddag-Miliani; François Le Loarer; Sylvain Causeret; Daniel Orbach; Michelle Kind; Louis-Romée Le Nail; Gwenaël Ferron; Hélène Labrosse; Loïc Chaigneau; François Bertucci; Jean-Christophe Ruzic; Valérie Le Brun Ly; Fadila Farsi; Emmanuelle Bompas; Sabine Noal; Aurore Vozy; Agnes Ducoulombier; Clément Bonnet; Sylvie Chabaud; Françoise Ducimetière; Camille Tlemsani; Mickaël Ropars; Olivier Collard; Paul Michelin; Justine Gantzer; Pascale Dubray-Longeras; Maria Rios; Pauline Soibinet; Axel Le Cesne; Florence Duffaud; Marie Karanian; François Gouin; Raphaël Tétreau; Charles Honoré; Jean-Michel Coindre; Isabelle Ray-Coquard; Sylvie Bonvalot; Jean-Yves Blay
Journal:  Cancers (Basel)       Date:  2022-05-25       Impact factor: 6.575

Review 7.  [Retroperitoneal soft tissue sarcoma: role of radiotherapy].

Authors:  Alexander Nieto; Markus Albertsmeier; Jens Werner; Dorit Di Gioia; Lars H Lindner; Josefine Rauch; Silke Nachbichler; Claus Belka; Nina-Sophie Schmidt-Hegemann
Journal:  Chirurg       Date:  2021-09-15       Impact factor: 0.955

8.  Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group.

Authors:  Carol J Swallow; Dirk C Strauss; Sylvie Bonvalot; Piotr Rutkowski; Anant Desai; Rebecca A Gladdy; Ricardo Gonzalez; David E Gyorki; Mark Fairweather; Winan J van Houdt; Eberhard Stoeckle; Jae Berm Park; Markus Albertsmeier; Carolyn Nessim; Kenneth Cardona; Marco Fiore; Andrew Hayes; Dimitri Tzanis; Jacek Skoczylas; Samuel J Ford; Deanna Ng; John E Mullinax; Hayden Snow; Rick L Haas; Dario Callegaro; Myles J Smith; Toufik Bouhadiba; Silvia Stacchiotti; Robin L Jones; Thomas DeLaney; Christina L Roland; Chandrajit P Raut; Alessandro Gronchi
Journal:  Ann Surg Oncol       Date:  2021-04-14       Impact factor: 4.339

9.  European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN.

Authors:  J-Y Blay; P Casali; C Bouvier; C Dehais; I Galloway; J Gietema; J Halámková; N Hindi; A Idbaih; E Kinloch; H-J Klümpen; T Kolarova; K Kopeckova; J Lovey; M Magalhaes; K Oselin; S Piperno-Neumann; A Ravnsbaek; M Rogasik; A Safwat; S Scheipl; M Seckl; J Taylor; M Temnyk; A Trama; M Urbonas; M Wartenberg; A Weinman
Journal:  ESMO Open       Date:  2021-06-14

10.  Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma.

Authors:  Makito Miyake; Yuki Oda; Nobutaka Nishimura; Yosuke Morizawa; Sayuri Ohnishi; Kinta Hatakeyama; Tomomi Fujii; Shunta Hori; Daisuke Gotoh; Yasushi Nakai; Satoshi Anai; Kazumasa Torimoto; Shinji Tsukamoto; Hiromasa Fujii; Akira Kido; Kanya Honoki; Yoshiaki Matsumura; Eijiro Okajima; Nobumichi Tanaka; Kiyohide Fujimoto
Journal:  Oncol Lett       Date:  2020-09-03       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.